SEPSIS project: a protocol for studying biomarkers of neonatal sepsis and immune responses of infants in a malaria-endemic region

Keyphrases

• Immune Response 100%
• Sepsis 100%
• Neonatal Sepsis 100%
• Malaria-endemic Countries 100%
• Neonate 50%
• Interleukin-10 25%
• Prematurity 25%
• Interleukin-6 25%
• Societal Burden 25%
• Malaria 25%
• Whole Blood 25%
• Limited Resources 25%
• Plasma Biomarkers 25%
• Peripheral Blood Mononuclear Cells 25%
• Neonatal Mortality 25%
• Live Birth 25%
• Phenotypic Characterization 25%
• Cord Blood 25%
• IP-10 25%
• CD74 25%
• Diagnostic Evaluation 25%
• CX3CR1 25%
• Prospective Longitudinal Study 25%
• Sepsis Diagnosis 25%
• Blood Response 25%
• Peer-reviewed Journals 25%
• Invasive Infection 25%
• Applique 25%
• Immunological Evaluation 25%
• Low-middle Income Countries 25%
• Neonatal Immune System 25%
• Benin 25%
• Sepsis Pathophysiology 25%
• Ethical Approval 25%
• Procalcitonin 25%
• Gestational Malaria 25%
• Recherche 25%
• Sepsis Prognosis 25%
• Sub-Saharan 25%
• Biomarker Performance 25%
• Epidemiological Evaluation 25%
• Translational Biomarkers 25%

Medicine and Dentistry

• Immune Response 100%
• Biological Marker 100%
• Neonatal Sepsis 100%
• Sepsis 75%
• Neonate 50%
• Diagnosis 25%
• Pathophysiology 25%
• Infection 25%
• Prematurity 25%
• Pathogen 25%
• Interleukin 10 25%
• Peripheral Blood Mononuclear Cell 25%
• Newborn Mortality 25%
• Transcriptomics 25%
• Cord Blood 25%
• Interleukin 6 25%
• Low and Middle Income Countries 25%
• Procalcitonin 25%

Immunology and Microbiology

• Immune Response 100%
• Blood Plasma 50%
• Infectious Agent 50%
• Interleukin 10 50%
• Interleukin 6 50%
• Newborn Mortality 50%
• Transcriptomics 50%
• CD74 50%
• Reference Value 50%
• Procalcitonin 50%
• CX3CR1 50%
• Peripheral Blood Mononuclear Cell 50%